8-K filing — CapsoVision, Inc (CV)
Filed: 2026-09-28 AccNo: 0001378325-26-000045 Size: 173 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83M
CapsoVision, Inc.3,163,444 Shares of Common Stock We are offering 3,163,444 shares of our common stock, par value $0.001 per share, under this prospectus supplement directly to a number of investors (collectively, the
CapsoVision Q2 2026 Earnings Call Transcript
CapsoVision (NASDAQ:CV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and